Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Life threatening pulmonary embolus in a factor V Leiden carrier on oral contraceptives: a case report.

Connecticut medicine - 1 Jun 1997

Saif M W, Volpe B T, Dailey M, Tsongalis G J

Abstract excerpt

Venous thromboembolism is a serious, potentially lethal health problem affecting one per 1,000 people annually. Major surgery, the use of oral contraceptives, complicated pregnancy, fractures, and immobilization increase the risk of thrombosis. In addition to these factors, thrombosis is associated with inherited deficiencies of antithrombin III, protein C, and protein S. Together these do not account for more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Heterozygote
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protein C

Share to Pulmonary Embolism

Share to Risk Factors

Source

Identifiers

PMID: 9238827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Life threatening pulmonary embolus in a factor V Leiden carrier on oral contraceptives: a case report.PMID 9238827Read ↗

Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Semantic proximity Read ↗

Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveSemantic proximity Read ↗

Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.Semantic proximity Read ↗

Venous thrombosis in older people: prevalence of the factor V gene mutation Q506.Semantic proximity Read ↗

Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.Semantic proximity Read ↗

Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.Semantic proximity Read ↗

Venous thromboembolism in a young woman with combined homozygosity for factor V Leiden and prothrombin G20210A mutations.Semantic proximity Read ↗

Chronic thromboembolic pulmonary hypertension in a patient heterozygous for both factor V Leiden and G20210 prothrombin mutation.Semantic proximity Read ↗

The Unexpected Clot: Unilateral Brachial Artery Occlusion Unmasking Antithrombin III Deficiency; Case Report and Therapeutic ConsiderationsSemantic proximity Read ↗

Factor V Leiden mutation and the risk of thrombo-embolic disease in pregnancy: a case report.Semantic proximity Read ↗

Resistance to activated protein C: a common inherited cause of venous thrombosis.Semantic proximity Read ↗

[Coincidence of 20210A prothrombin variant and factor V Leiden predisposing to venous thromboembolism].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.